Navigation Links
Spectral announces 2008 financial results
Date:3/12/2009

TORONTO, March 12 /PRNewswire-FirstCall/ - Spectral Diagnostics Inc. (TSX:SDI) today announced its operational highlights and financial results for the fiscal year ended December 31, 2008.

"In 2008, we accomplished several key objectives on our path to delivering an effective treatment for severe sepsis for the U.S. market," said Dr. Paul Walker, President and CEO of Spectral. "In September, we agreed to key terms with Toray Industries, Inc. (Toray) of Japan to obtain the exclusive development and commercial rights in the U.S. for Toraymyxin(TM), a therapeutic for the treatment of sepsis that removes endotoxin from the bloodstream, and which has been used on more than 70,000 patients to date, primarily in Europe and Japan. Together with our proprietary Endotoxin Activity Assay (EAA(TM)), used for measuring endotoxin levels in the blood, the combination has demonstrated a dramatic reduction in the mortality of patients with severe sepsis compared to standard of care in European trials. Spectral's current focus is to seek FDA clearance for the therapeutic product."

    Highlights from 2008:

    -   Agreed to key terms with Toray, in September 2008, to obtain the
        exclusive development and commercial rights in the U.S. for
        Toraymyxin(TM). The Company will now seek FDA clearance for this
        product. The final license and supply agreement with Toray was signed
        subsequent to the year end on March 6, 2009.

    -   Presented findings showing the clinical effectiveness of EAA(TM) to
        identify patients with elevated endotoxin levels and to guide
        endotoxin reducing strategies at a symposium entitled "Blood
        Purification in the Treatment of Sepsis," at the International Shock
        Congress in Cologne, Germany in June 2008.

    -   Entered into an exclusive distribution agreement in July 2008 with BB
        Medical, a leading distributor of medical technologies in Russia, 
'/>"/>
SOURCE Spectral Diagnostics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Spectral signs exclusive license agreement to bring sepsis therapeutic to the U.S. market
2. Surface plasmon resonances of metal nanoparticles in array can have narrower spectral widths
3. Spectral announces third quarter 2008 results
4. Spectral to bring anti-sepsis therapy to the U.S. market
5. Spectral announces exclusive distribution agreement in Russia for its EAA(TM) Sepsis Diagnostic Assay
6. Spectral announces continuing support for the combination of EAA(TM) and anti-endotoxin therapeutics
7. Spectral announces presentation of data on improving sepsis patient management with EAA(TM) and Toraymyxin(TM) combination
8. Spectral and Toray expand collaboration to include new geographic territories
9. Spectrals EAA(TM) to be used in Phase III study for a sepsis anti-endotoxin therapy
10. Spectral announces new findings on the effectiveness of EAA(TM)/Toraymyxin(TM) at the 28th International Symposium on Intensive Care and Emergency Medicine
11. Spectral announces 2007 financial results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... N.J. , July 24, 2014 ... provider of regulatory and ethical review services for ... Alliance Biosciences. Formerly a division of ... was the leading biosafety and biosecurity consulting firm ... With this addition, WCG,s biosafety division – WCG ...
(Date:7/24/2014)... 2014 The first part of the ... First in Human Studies” will cover comprehensive clinical support ... , With increasing R&D costs and declining industry success ... maximize the knowledge collected in early Phase I/IIa study ... in late stage development. , Next, the presenters will ...
(Date:7/24/2014)... Md. , July 24, 2014  Spherix Incorporated ... the fostering and monetization of intellectual property, today announced ... the period ending June 30, 2014 on Monday, August ... call at 10 a.m. ET on Monday, August 18, ... be led by the company,s CEO, Anthony Hayes ...
(Date:7/24/2014)... Bound Brook, NJ (PRWEB) July 24, 2014 ... expects to manage numerous projects in the MENA region ... delighted to have a preferred provider agreement with DZS ... in the MENA region,” said Global VP of R&D ... "DZS has developed excellent operational practices with a ...
Breaking Biology Technology:WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 2WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 3Best Practices for Optimizing Dose Escalation in First in Human Studies, New Webinar August 6th Hosted by Xtalks 2Spherix Schedules Shareholder Update Call 2SBI Pharmaceuticals Co. Ltd. Enters into Preferred Provider Agreement with DZS Clinical Services 2
... integrated data that combines business and technology strategies, is ... murky technology concept it is a leading-edge business ... convergence allows companies to communicate more completely and at ... the bottom line. , ,In my own experience, ...
... help cell-phone users take advantage of the limitless minutes ... engineers have developed a device that can significantly improve ... battery power. , ,"When you've been talking on a ... how hot it gets," notes Zhenqiang "Jack" Ma, an ...
... laboratory" of teaching technology will use Mediasite Live, ... Foundry, Inc. , to automatically record, distribute, archive ... , ,The laboratory, termed the Digital Union, is ... making informed investment decisions across Ohio's flagship campus ...
Cached Biology Technology:WTN Visions: Convergence is changing business 2WTN Visions: Convergence is changing business 3UW-Madison technology to advance cell phones 2UW-Madison technology to advance cell phones 3Ohio State's educational tech lab to use Sonic Foundry system 2
(Date:7/24/2014)... NJIT this week for an all-day public forum on ... Agency (EPA) to dredge toxic sediment from an eight-mile ... has called the plan, which proposes removing 4.3 million ... the riverbed, one of the largest cleanups in the ... disposed off-site. , "We need to ensure the future ...
(Date:7/24/2014)... is currently conducting research into the potato genes that ... by a reduction in rainfall and increased extremes of ... most resistant genes in order to create new potato ... research is also seeking to find out how the ... greater drought and higher and lower temperatures. , This ...
(Date:7/24/2014)... successfully treated lupus in mice, a biomedical engineer at the ... his research to a new version of the drug in ... Chandra Mohan, Hugh Roy and Lillie Cranz Cullen Endowed Professor ... Arthritis Research & Therapy outlining the use of a new ... number of cases of lupus-related kidney disease., He now has ...
Breaking Biology News(10 mins):Experts Weigh the Pros and Cons of a $1.7 Billion EPA Cleanup Plan for the Passaic River at an NJIT 2Neiker-Tecnalia is researching the potato genes that best adapt to climate change 2Biomedical engineer looks at new applications for novel lupus drug 2Biomedical engineer looks at new applications for novel lupus drug 3
... states that when dinosaurs died and became fossilized, ... transformed into "rocks" through a gradual replacement of ... a North Carolina State University paleontologist, however, could ... Mary Schweitzer, assistant professor of paleontology with a ...
... may be in its infancy, but biologists may soon ... living cell like never before. Scientists at the U.S. ... and Lawrence Livermore National Laboratory have developed a way ... can track life's fundamental processes, such as DNA repair, ...
... has,found the first clear evidence that the process ... and respond to a million,different proteins might have ... function is to jump around in genetic material., ... genetic material, and scientists,have suspected that this ability ...
Cached Biology News:NC State scientist finds soft tissue in T. rex bones 2Nano-Probes Allow an Inside Look at Cell Nuclei 2Nano-Probes Allow an Inside Look at Cell Nuclei 3UCSD Discovery Shows How Embryonic Stem Cells Perform 'Quality Control' Inspections 2UCSD Discovery Shows How Embryonic Stem Cells Perform 'Quality Control' Inspections 3
Anti-MMP-14, catalytic domain, clone LEM-2/15.8 Immunogen: Synthetic peptide: amino acid sequence 218-233 within the catalytic domain Available Date: 38579...
Anti-MMP-14, catalytic domain, clone LEM-2/15.8 Immunogen: Synthetic peptide: amino acid sequence 218-233 within the catalytic domain Available Date: 38579...
Anti-MMP-19 (RASI), carboxy terminal region; rabbit host...
Rabbit anti MMP-13, Hinge Region MMP-13 Hinge Region...
Biology Products: